Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome
Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...
| Үндсэн зохиолчид: | , , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | Russian |
| Хэвлэсэн: |
«FIRMA «SILICEA» LLC
2004-12-01
|
| Цуврал: | Российский кардиологический журнал |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://russjcardiol.elpub.ru/jour/article/view/2326 |